SEC FORM 4
$201,867.48
CRISPR Therapeutics AG (CRSP)
Sale of 4,098 shares at $49.26 per share.
Reporting Person Kulkarni Samarth · Officer Title Chief Executive Officer · Transaction Code S
Traded Oct 14, 2026 · Disclosed Oct 15, 2026
Source: SEC Form 4 · 0001193125-26-423056 · filed 2026-10-15 · View filing →